NCT02895074

Brief Summary

To compare the effects of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification surgery (CPS) on subfoveal choroidal thickness (SFCT) in age-related cataracts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
Last Updated

September 9, 2016

Status Verified

September 1, 2016

Enrollment Period

10 months

First QC Date

August 29, 2016

Last Update Submit

September 5, 2016

Conditions

Keywords

femtosecond laser-assisted cataract surgery (FLACS)subfoveal choroidal thickness (SFCT)conventional phacoemulsification surgery (CPS)

Outcome Measures

Primary Outcomes (1)

  • The change of subfoveal choroidal thickness

    The subfoveal choroidal thickness were measured at baseline and at 1 day, 7 days , 1 month , and 3 months postoperatively by spectral-domain optical coherence tomography.

    baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery

Secondary Outcomes (1)

  • The change of subfoveal retinal thickness

    baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery

Study Arms (2)

femtosecond laser-assisted cataract surgery group

EXPERIMENTAL
Procedure: Femtosecond laser-assisted cataract surgeryDrug: TropicamideDrug: Proparacaine hydrochloride

conventional phacoemulsification surgery group

EXPERIMENTAL
Procedure: Conventional phacoemulsification cataract surgeryDrug: TropicamideDrug: Proparacaine hydrochloride

Interventions

A femtosecond laser (Alcon-Lensx, Alcon-Lensx, Inc.) was used in this study. After pupil dilation and topical anesthesia, the laser was docked to the eye using a curved contact lens to applanate the cornea. With the integrated OCT imaging system, the locations of the cornea and the anterior and posterior surfaces of the crystalline lens were determined. A 5.0-mm-diameter capsulotomy was created by scanning a cylindrical pattern and followed by lens fragmentation. The laser was disconnected, and the remainder of the surgery was performed as phacoemulsification (Infiniti® Vision System; Alcon, USA). Folded intraocular lenses (IOLs) were implanted in the capsular bags.

femtosecond laser-assisted cataract surgery group

Phacoemulsification was performed through a temporal 3.2-mm clear corneal incision with the same machine and followed by IOLs implantation.

conventional phacoemulsification surgery group

After pupil dilation, 1 drop of tropicamide (0.5%) was applied every 15 minutes for 3 applications

conventional phacoemulsification surgery groupfemtosecond laser-assisted cataract surgery group

topical anesthesia with proparacaine hydrochloride (0.5%) was applied.

conventional phacoemulsification surgery groupfemtosecond laser-assisted cataract surgery group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • The cataract stages of the patients were between N2 and N4 according to the LOCS III.

You may not qualify if:

  • eyes with histories of ocular surgery, trauma, and ocular diseases, including diabetic retinopathy, age-related macular degeneration (AMD), high myopia, psudoexfoliation, uveitis, retinal vein occlusion, and other inflammatory and vascular retinal disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center, Sun Yat-sen University

Guangzhou, Guangdong, 510060, China

Location

Related Publications (1)

  • Chen X, Xiao W, Ye S, Chen W, Liu Y. Efficacy and safety of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification for cataract: a meta-analysis of randomized controlled trials. Sci Rep. 2015 Aug 13;5:13123. doi: 10.1038/srep13123.

    PMID: 26269445BACKGROUND

Related Links

MeSH Terms

Conditions

Cataract

Interventions

Tropicamideproxymetacaine

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

PyridinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Officials

  • Haotian Lin, M.D., Ph.D

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    PRINCIPAL INVESTIGATOR
  • Yizhi Liu, M.D., Ph.D

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY CHAIR
  • Weirong Chen, M.D.

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Home for Cataract Children, Zhongshan Ophthalmic Center

Study Record Dates

First Submitted

August 29, 2016

First Posted

September 9, 2016

Study Start

August 1, 2014

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

September 9, 2016

Record last verified: 2016-09

Locations